Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Integrin ab Expression in Lung Cancer Patients for Clinical Application of Cancer-Target Fluorescent Contrast Agent for Image-Induced Precise Lung Cancer Surgery

NCT06167941 is registered in ClinicalTrials.gov with Korea University Guro Hospital as lead sponsor.

NCT NCT06167941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06167941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Integrin ab Expression in Lung Cancer Patients for Clinical Application of Cancer-Target Fluorescent Contrast Agent for Image-Induced Precise Lung Cancer Surgery
Lead sponsor
Korea University Guro Hospital
Phase
Observational
Overall status
Completed
Start date
December 19, 2019
Completion date
November 25, 2021
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

expression of integrin ανβ3 in lung cancer